国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Nanotechnology in Pharmaceutical Delivery System

Zhen Huang

Nanotechnology has revolutionized the field of drug delivery in the pharmaceutical industry. With the development of Nano scale particles and structures, drugs can now be targeted and delivered to specific sites within the body with greater precision and efficacy. One of the key advantages of nanotechnology in drug delivery is the ability to increase drug solubility, bioavailability, and stability. This is achieved by encapsulating drugs in Nano scale particles, which can protect them from degradation and enhance their absorption in the body. Additionally, nanoscale drug delivery systems can be designed to release drugs in a controlled manner, ensuring sustained therapeutic effects and minimizing potential side effects. Furthermore, nanotechnology-based delivery systems can be engineered to selectively target diseased cells or tissues, thereby reducing off-target effects and improving treatment outcomes. Overall, the use of nanotechnology in pharmaceutical delivery systems holds great promise for improving the effectiveness and safety of drug therapies. As such, it is an area of active research and development in the pharmaceutical industry.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。